Literature for inhibitor I08.950: von Willebrand factor
-
Turecek,P.L., Peck,R.C., Rangarajan,S., Reilly-Stitt,C., Laffan,M.A., Kazmi,R., James,I., Dushianthan,A., Schrenk,G., Gritsch,H., Ewenstein,B.M., Mellgard,B., Erdlenbruch,W., Jain,N., Binder,N.B. and Mumford,A.D.
Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19
Thromb Res (2021) 201, 100-112. PubMed Europe PubMed DOI PMC EPMC -
Moller,C., Schutte,A.E., Smith,W. and Botha-Le Roux,S.
Von Willebrand factor, its cleaving protease (ADAMTS13), and inflammation in young adults: The African-PREDICT study
Cytokine (2020) 136, 155265-155265. PubMed Europe PubMed DOI
2021
2020
